This report provides exclusive insights into the COVID-19 impact on the Cyberknife Market . The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Cyberknife Market . Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Cyberknife Market . The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on the cyberknife market provides an in-depth analysis of segments and sub-segments in
the global as well as regional cyberknife market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
cyberknife market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of the global
cyberknife market. According to the report, the global cyberknife market is
projected to grow at a CAGR of 9.2% over the forecast period of 2019-2025.
Cyberknife is a stereotactic radiosurgery system used in the
treatment of benign cancers, malignant cancers without affecting healthy cells.
Nowadays it is also used in the treatment of the cancer of the pancreas, liver,
lung, prostate, spine, and cancer of the throat. For lung cancer, it uses
Synchrony software during radiotherapy well as it can function properly even
the patient is breathing. As it uses the surgical placed internal fiducials and
light-emitting optical fibers with combination, mounted on the patient body
where the optical fibers are tracked by infrared tracking camera. Therefore, it
is called the synchrony system or synchrony method. It takes 1 to 5 days to
complete the treatment while each treatment session lasts between 30 to 90
minutes. Recently, it is the only produced in the market that offers robotic
The increasing prevalence of the various types of cancer such
as pancreas, liver, lung, prostate, spine, and cancer of throat boosts the
growth of the market. According to the WHO, in 2018, cancer is the second
leading cause of death globally as well as an estimated 9.6 million deaths due
to cancer. On the other hand, according to the National Cancer Institute, in
2017, 15,270 children between 0 to 19 ages were diagnosed with cancer and 1,790
children were dead. Cyberknife radiotherapy system ensures targeted delivery of
the radiotherapy to the cancerous cells as well as prevents the multiplication
of the cells. It provides accurate as well as precise treatment. Hence, these
factors enhance the growth of the market. On the other hand, growing
non-invasive and minimally-invasive procedures as well as the adoption of the cyberknife in the developed countries propel the growth of the market. Besides,
the manufacturer is involved in the development of the product with the advance
technologies are bring the cyberknife in the great demand in the market. The
government is also taking initiative towards funding in the research activities
to launch a new product. Thereby, these increasing initiatives by the
government drive the growth of the market. The increasing geriatric population
also boosts the growth of the market. However, lack of awareness about the cyberknife yet remains one of the
major restraints to this market. Besides, for operating the cyberknife for the
treatment of the various types of cancer such as liver, lung, prostate, spine,
cancer of the throat, pancreas requires skilled professionals. The skill
professionals in developing countries are less. Therefore, the lack of skilled
professionals is another factor that hinders the growth of the market.
Based on the region, North America holds the highest market
share of the cyberknife radiation therapy for lung cancer treatment market due
to the rising incidences of lung cancer. In addition, the occurrence of highly
advanced medical treatments in the region also boosts the growth of this
market. Europe holds the second largest market share in this market due to the growing
number of cases of cancer as well as increasing demand for the cyberknife
radiotherapy technique. On the other hand, Asia Pacific is expected to grow at
the highest CAGR in the forecast period as the healthcare infrastructure is
developing at a fast pace especially in countries such as India.
The report on global cyberknife market covers segments such as
application, and end user. On the basis of application, the sub-markets include
lung cancers, brain cancer, liver cancer, pancreas cancer, and other
applications. On the basis of end user, the sub-markets include hospitals,
clinics, ambulatory surgical center, radiotherapy centers, and other end users.
The report provides profiles of the companies in the market
such as GE Healthcare, Accuray Incorporated, Elekta AB, Nucletron B.V., Hitachi
America, IBA Group, Mitsubishi Electric, Nordion Inc., Philips Healthcare,
Varian Medical Systems, and Sumitomo Heavy Industries.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the cyberknife market.
Moreover, the study highlights current market trends and provides forecast from
2019-2025. We also have highlighted future trends in the market that will
affect the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight into the market share
of the leading players.